- Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer2011 | Third Faculty of Medicine
- Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study2015 | Faculty of Medicine in Hradec Králové
- The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials2021 | First Faculty of Medicine, Second Faculty of Medicine
